RO-600332

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameRO-600332
Drug Alias NameORG-35035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsDepressive Disorder, MajorPanic DisorderObsessive-Compulsive Disorder +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorPanic DisorderObsessive-Compulsive Disorder +[4] 

Other Information

ATC CodeN/A
Related LinksN/A